Delphic specialises in pharmacology, pharmacogenetics and virology. It has extensive experience in method development, method transfer and the design and development of trial protocols. It has particular expertise in infectious diseases, including world-leading pharmacology and clinical excellence in HIV and hepatitis.

Delphic has the combined experience of over 150 clinical trials from inception and design through to bioanalysis of single or batched samples received from sites throughout the world.

Our dedicated pharmacology laboratory, acquired from and with continuing academic links to the University of Liverpool, has the scientific expertise and high-end instrumentation required to develop assays across most therapy areas, together with the ability to design PK studies and create interpretative algorithms.

The conjunction of our proficiency in pharmacology with our ability to develop biomarker assays gives our clients a competitive edge in the emergent market for adaptive clinical trials and personalised medicine.